Apr. 15: Supreme Court Series – Association for Molecular Pathology v. Myriad Genetics, Post Argument Discussion

 

Mar 25, 2013 | Room 602
Event: 4:30 | Reception: 5:50
American University Washington College of Law
4801 Massachusetts Ave NW
Washington DC, 20016 (map)

 In PIJIP’s ongoing Supreme Court series, counsel for parties and amici will discuss intellectual property cases on the afternoon of oral argument, addressing the reaction of the Court at oral argument.

Panel:

  • Chris Hansen, American Civil Liberties Union Foundation, Counsel for Petitioners, Association for Molecular Pathology, et al.
  • Joshua Sarnoff, Center for Intellectual Property Law and Information Technology, DePaul University College of Law, Counsel for Amici, Fifteen Law Professors, in Support of Petitioners
  • Gregory Dolin, University of Baltimore/Johns Hopkins University Center for Law and Medicine, Counsel for Amici, University of Baltimore School of Law/Johns Hopkins University School of Medicine Center for Law and Medicine & Law Professors Gregory Dolin, M.D., et al, in Support of Respondents
  • David Forman, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Counsel for Amicus, Target Discovery, Inc., in Support of Affirmance 
  • Arti Rai, Duke University School of Law, Commentator

Moderated by Jorge Contreras, American University Washington College of Law

Update:

Decision: June 13, 2013
Argument: Transcript; Audio

Issue:

Whether human genes are patentable.

Briefs

Brief for Petitioners Association for Molecular Pathology, et al.
Brief for Respondents Myriad Genetics, Inc., et al.

Amicus Briefs

National Women’s Health Network Amicus Brief
AARP Amicus Brief
Cancer Council Australia, et al. Amicus Brief
Kali N. Murray and Erika R. George Amicus Brief
Canavan Foundation, et al. Amicus Brief
American Medical Association, et al. Amicus Brief
Juhasz Law Firm, PC Amicus Brief
GeneDx and Law Professors Amicus Brief
Federation Internationale Des Conseils En Propriete Intellectuelle Amicus Brief
Academics in Law, Medicine, Health Policy and Clinical Genetics Amicus Brief
CLS Bank International Amicus Brief
United States Amicus Brief
International Center for Technology Assessment Amicus Brief
Genformatic LLC Amicus Brief
James D. Watson, Ph.D. Amicus Brief
Fifteen Law Professors Amicus Brief
Sigram Schindler Beteiligungsgellschaft Amicus Brief
Institute of Professional Representative Before the EPI Amicus Brief
Ethics & Religious Liberty Commission of the Southern Baptist Convention Amicus Brief
Eric S. Lander Amicus Brief
American Intellectual Property Association Amicus Brief
Prof. Eileen M. Kane Amicus Brief
Knowledge Ecology International Amicus Brief
InVitae Corporation Amicus Brief
Animal Health Institute and Merial Limited Amicus Brief
Philadelphia Intellectual Property Law Association Amicus Brief
Association of American Physicians & Surgeons, et al. Amicus Brief
Federal Circuit Bar Association Amicus Brief
NanoBusiness Commercialization Association Amicus Brief
CropLife International Amicus Brief
Coalition for 21st Century Medicine Amicus Brief
Target Discovery, Inc. Amicus Brief
Boston Patent Law Association Amicus Brief
Inmatics Biotechnologies, GmbH Amicus Brief
National Venture Capital Association Amicus Brief
Dr. Ananda Mohan Chakrabarty Amicus Brief
University of Baltimore/Johns Hopkins University Center for Medicine & Law Amicus Brief
MPEG LA, LLC Amicus Brief
New York Intellectual Property Law Association Amicus Brief
American Bar Association Amicus Brief
Intellectual Property Amicus Brief Clinic of the Franklin Pierce Center for IP Amicus Brief
Prof. Jeffrey A. Lefstin Amicus Brief
Lynch Syndrome International Amicus Brief
Intellectual Property Owners Association Amicus Brief
Pharmaceutical Research and Manufacturers of America Amicus Brief
Drs. Larry Geier, William Harb, Adam Ofer, and Donald Aptekar Amicus Brief
In House Patent Counsel, LLC Amicus Brief
Gilead Sciences, Inc., et al. Amicus Brief
Biotechnology Industry Association Amicus Brief 

SCOTUSblog Entry: Association for Molecular Pathology v. Myriad Genetics, Inc.